Alteration of antithrombin III and D-dimer levels in clinically localized prostate cancer

Korean Journal of Urology

Volumn 51, Issue 1, 2010, Pages 25-29

  Hong, Sung Kyu ^a   Ko, Dong Woo ^a   Park, Juhyun ^a   Kim, In Sung ^a   Doo, Seung Hwan ^a   Yoon, Cheol Yong ^a   Park, Hongzoo ^a   Lee, Won Ki ^a   Kim, Dae Sung ^a   Jeong, Seong Jin ^a   Byun, Seok Soo ^a   Lee, Sang Eun ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Blood coagulation tests; Prostatic neoplasms

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR; D DIMER; FIBRINOGEN; PLASMINOGEN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CANCER GRADING; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER;

EID: 76749148061     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2010.51.1.25     Document Type: Article

References (19)

1. Bick RL. Coagulation abnormalities in malignancy: a review. Semin Thromb Hemost 1992;18:353-72.
2. Constantini V, Zacharski LR. Fibrin and cancer. Thromb Haemost 1993;69:406-14.
3. Donati MB, Falanga A. Pathogenetic mechanisms of thrombosis in malignancy. Acta Haematol 2001;106:18-24.
4. Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev 1992;11:237-48.
5. Falanga A, Rickles FR. Pathophysiology of the thrombophilic state in the cancer patient. Semin Thromb Hemost 1999;25:173-82.
6. Kilic M, Yoldas O, Keskek M, Ertan T, Tez M, Gocmen E, et al. Prognostic value of plasma D-dimer levels in patients with colorectal cancer. Colorectal Dis 2008;10:238-41.
7. Dirix LY, Salgado R, Weytjens R, Colpaert C, Benoy I, Huget P, et al. Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br J Cancer 2002;86:389-95.
8. Koh SC, Tham KF, Razvi K, Oei PL, Lim FK, Roy AC, et al. Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome? Clin Appl Thromb Hemost 2001;7:141-8.
9. Unsal E, Atalay F, Atikcan S, Yilmaz A. Prognostic significance of hemostatic parameters in patients with lung cancer. Respir Med 2004;98:93-8.
10. Cao Y, Lundwall A, Gadaleanu V, Lilja H, Bjartell A. Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2. Am J Pathol 2002;161: 2053-63.
11. Beecken WD, Bentas W, Engels K, Glienke W, Urbschat A, Jonas D, et al. Reduced plasma levels of coagulation factors in relation to prostate cancer. Prostate 2002;53:160-7.
12. Caine GJ, Lip GY, Stonelake PS, Ryan P, Blann AD. Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma. Thromb Haemost 2004;92:185-90.
13. Oya M, Akiyama Y, Okuyama T, Ishikawa H. High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. Jpn J Clin Oncol 2001;31:388-94
14. Langer F, Chun FK, Amirkhosravi A, Friedrich M, Leuenroth S, Eifrig B, et al. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers. Thromb Haemost 2007;97: 464-70.
15. Shariat SF, Roehrborn CG, McConnell JD, Park S, Alam N, Wheeler TM, et al. Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis. J Clin Oncol 2007;25:349-55.
16. Kohli M, Kaushal V, Mehta P. Role of coagulation and fibrinolytic system in prostate cancer. Semin Thromb Hemost 2003;29:301-8.
17. Blackwell K, Haroon Z, Broadwater G, Berry D, Harris L, Iglehart JD, et al. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. J Clin Oncol 2000;18:600-8.
18. Kim TH, Yang DY, Kim SY, Kim H, Yoo HS, Choi H, et al. Evaluation of the changes of coagulation-fibrinolysis system during transurethral resection of the prostate by thromboelastography. Korean J Urol 1997;38:1217-22.
19. Browder T, Folkman J, Pirie-Shepherd S. The hemostatic system as a regulator of angiogenesis. J Biol Chem 2000;275:1521-4.